5djc

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (21:43, 28 June 2023) (edit) (undo)
 
Line 3: Line 3:
<StructureSection load='5djc' size='340' side='right'caption='[[5djc]], [[Resolution|resolution]] 2.10&Aring;' scene=''>
<StructureSection load='5djc' size='340' side='right'caption='[[5djc]], [[Resolution|resolution]] 2.10&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[5djc]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5DJC OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5DJC FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[5djc]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5DJC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5DJC FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=GAL:BETA-D-GALACTOSE'>GAL</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5di8|5di8]], [[5dj0|5dj0]], [[5dj2|5dj2]], [[5dj6|5dj6]], [[5dj8|5dj8]], [[5dja|5dja]], [[5djd|5djd]], [[5djx|5djx]], [[5djy|5djy]], [[5djz|5djz]], [[5dk0|5dk0]], [[5dk2|5dk2]], [[5dvk|5dvk]], [[5dvl|5dvl]], [[5dvm|5dvm]], [[5dvn|5dvn]], [[5dvo|5dvo]]</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=GAL:BETA-D-GALACTOSE'>GAL</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">IGHG1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5djc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5djc OCA], [https://pdbe.org/5djc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5djc RCSB], [https://www.ebi.ac.uk/pdbsum/5djc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5djc ProSAT]</span></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5djc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5djc OCA], [http://pdbe.org/5djc PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5djc RCSB], [http://www.ebi.ac.uk/pdbsum/5djc PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5djc ProSAT]</span></td></tr>
+
</table>
</table>
== Disease ==
== Disease ==
-
[[http://www.uniprot.org/uniprot/IGHG1_HUMAN IGHG1_HUMAN]] Defects in IGHG1 are a cause of multiple myeloma (MM) [MIM:[http://omim.org/entry/254500 254500]]. MM is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IGHG1 is found in multiple myeloma. Translocation t(11;14)(q13;q32) with the IgH locus. Translocation t(11;14)(q13;q32) with CCND1; translocation t(4;14)(p16.3;q32.3) with FGFR3; translocation t(6;14)(p25;q32) with IRF4.
+
[https://www.uniprot.org/uniprot/IGHG1_HUMAN IGHG1_HUMAN] Defects in IGHG1 are a cause of multiple myeloma (MM) [MIM:[https://omim.org/entry/254500 254500]. MM is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IGHG1 is found in multiple myeloma. Translocation t(11;14)(q13;q32) with the IgH locus. Translocation t(11;14)(q13;q32) with CCND1; translocation t(4;14)(p16.3;q32.3) with FGFR3; translocation t(6;14)(p25;q32) with IRF4.
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/IGHG1_HUMAN IGHG1_HUMAN]
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 24: Line 25:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Human]]
+
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Aldaz, H]]
+
[[Category: Synthetic construct]]
-
[[Category: Atwell, S]]
+
[[Category: Aldaz H]]
-
[[Category: Chamberlain, A K]]
+
[[Category: Atwell S]]
-
[[Category: Demarest, S J]]
+
[[Category: Chamberlain AK]]
-
[[Category: Dhanani, S H]]
+
[[Category: Demarest SJ]]
-
[[Category: Fitchett, J R]]
+
[[Category: Dhanani SH]]
-
[[Category: Froning, K J]]
+
[[Category: Fitchett JR]]
-
[[Category: Gutierrez, B]]
+
[[Category: Froning KJ]]
-
[[Category: Hendle, J]]
+
[[Category: Gutierrez B]]
-
[[Category: Huang, F]]
+
[[Category: Hendle J]]
-
[[Category: Kuhlman, B]]
+
[[Category: Huang F]]
-
[[Category: Leaver-Fay, A]]
+
[[Category: Kuhlman B]]
-
[[Category: Lu, F]]
+
[[Category: Leaver-Fay A]]
-
[[Category: Pustilnik, A]]
+
[[Category: Lu F]]
-
[[Category: Secrist, E]]
+
[[Category: Pustilnik A]]
-
[[Category: Yuan, R]]
+
[[Category: Secrist E]]
-
[[Category: Bispecific antibody]]
+
[[Category: Yuan R]]
-
[[Category: Ch3]]
+
-
[[Category: Fc]]
+
-
[[Category: Heterodimer]]
+
-
[[Category: Immune system]]
+
-
[[Category: Immunoglobulin]]
+

Current revision

Fc Heterodimer Design 8.1 L368V/Y407A + T366V/K409F

PDB ID 5djc

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools